ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,101.24
-0.29%
Dow Jones
44,424.25
-0.32%
US Dollar vs MXN
20.2749
0.00%
Brent Oil
77.625
0.00%
Bitcoin
104,570.29
-0.15%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. CNS Pharmaceuticals Inc (CNSP)

  7. CNS Pharmaceuticals Inc (CNSP) Noticias

CNSP

CNS Pharmaceuticals (CNSP)

CNS Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CNSP
FechaHoraFuenteTítuloSímboloCompañía
11/12/202411:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CNSPCNS Pharmaceuticals Inc
15/11/202415:19Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:CNSPCNS Pharmaceuticals Inc
14/11/202416:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CNSPCNS Pharmaceuticals Inc
28/10/202415:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CNSPCNS Pharmaceuticals Inc
24/10/202410:23Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CNSPCNS Pharmaceuticals Inc
15/10/202416:24Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CNSPCNS Pharmaceuticals Inc
03/09/202407:00GlobeNewswire Inc.IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.NASDAQ:CNSPCNS Pharmaceuticals Inc
06/08/202416:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CNSPCNS Pharmaceuticals Inc
06/08/202415:53Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CNSPCNS Pharmaceuticals Inc
04/08/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CNSPCNS Pharmaceuticals Inc
02/08/202415:11Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:CNSPCNS Pharmaceuticals Inc
31/07/202411:32Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:CNSPCNS Pharmaceuticals Inc
30/07/202416:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CNSPCNS Pharmaceuticals Inc
19/07/202416:12Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:CNSPCNS Pharmaceuticals Inc
12/07/202415:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:CNSPCNS Pharmaceuticals Inc
09/05/202416:28Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CNSPCNS Pharmaceuticals Inc
31/01/202415:27Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:CNSPCNS Pharmaceuticals Inc
12/10/202317:01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CNSPCNS Pharmaceuticals Inc
15/05/202307:40Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNSPCNS Pharmaceuticals Inc
15/05/202307:39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNSPCNS Pharmaceuticals Inc
09/05/202316:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CNSPCNS Pharmaceuticals Inc
01/05/202318:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNSPCNS Pharmaceuticals Inc
31/03/202316:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CNSPCNS Pharmaceuticals Inc
29/03/202308:05PR Newswire (US)CNS Pharmaceuticals to Present at the Virtual Investor GBM Spotlight EventNASDAQ:CNSPCNS Pharmaceuticals Inc
13/03/202306:05PR Newswire (US)CNS Pharmaceuticals Announces it Has No Exposure to Silicon Valley Bank IssuesNASDAQ:CNSPCNS Pharmaceuticals Inc
09/03/202308:05PR Newswire (US)CNS Pharmaceuticals Continues Momentum in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM with First Patient Enrolled in SwitzerlandNASDAQ:CNSPCNS Pharmaceuticals Inc
14/02/202311:24Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNSPCNS Pharmaceuticals Inc
07/02/202307:45PR Newswire (US)CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBMNASDAQ:CNSPCNS Pharmaceuticals Inc
12/01/202307:45PR Newswire (US)CNS Pharmaceuticals Announces Investigator-Initiated Phase 1b/2 Trial to be Conducted at the Pomeranian Medical University in PolandNASDAQ:CNSPCNS Pharmaceuticals Inc
05/01/202308:05PR Newswire (US)CNS Pharmaceuticals to Present at the Virtual Investor 2023 Companies to Watch EventNASDAQ:CNSPCNS Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNSP

Su Consulta Reciente

NYSE
AXP
American Express
PM
XAUUSD
Gold vs US Dollar
NYSE
VZ
Verizon Communications
FX
USDMXN
US Dollar vs MXN
AMEX
XLV
Health Care Select Sector
FX
EURMXN
Euro vs MXN
NYSE
DIS
Walt Disney
NYSE
CVX
Chevron
NASDAQ
GOOGL
Alphabet
COIN
XRPUSD
Ripple
NYSE
MRK
Merck
AMEX
XLF
Financial Select Sector
SPI
SP500
S&P 500
COIN
ADAUSD
Cardano
CCOM
US500
US 500
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados